MMP2 and liver cancer: In the liver cancer, DLX6-AS1 could enhance WEE1 expression via targeting miR-424-5p to aggregate the liver cancer progression [20]; in addition, DLX6-AS1 promoted liver cancer carcinogenesis via targeting the miR-203a/matrix metalloproteinase-2 axis [21].